nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—islet of Langerhans—type 2 diabetes mellitus	0.0328	0.152	CbGeAlD
Mupirocin—IARS—retina—type 2 diabetes mellitus	0.028	0.13	CbGeAlD
Mupirocin—IARS—nephron tubule—type 2 diabetes mellitus	0.0264	0.123	CbGeAlD
Mupirocin—IARS—cardiovascular system—type 2 diabetes mellitus	0.0237	0.11	CbGeAlD
Mupirocin—IARS—kidney—type 2 diabetes mellitus	0.0232	0.108	CbGeAlD
Mupirocin—IARS—pancreas—type 2 diabetes mellitus	0.0231	0.107	CbGeAlD
Mupirocin—IARS—cortex of kidney—type 2 diabetes mellitus	0.0226	0.105	CbGeAlD
Mupirocin—IARS—adipose tissue—type 2 diabetes mellitus	0.0209	0.0971	CbGeAlD
Mupirocin—IARS—liver—type 2 diabetes mellitus	0.0147	0.0681	CbGeAlD
Mupirocin—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00272	0.00347	CcSEcCtD
Mupirocin—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00272	0.00347	CcSEcCtD
Mupirocin—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00271	0.00346	CcSEcCtD
Mupirocin—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00271	0.00345	CcSEcCtD
Mupirocin—Rash—Tolazamide—type 2 diabetes mellitus	0.00271	0.00345	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Ramipril—type 2 diabetes mellitus	0.00271	0.00345	CcSEcCtD
Mupirocin—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.0027	0.00345	CcSEcCtD
Mupirocin—Headache—Tolazamide—type 2 diabetes mellitus	0.00269	0.00343	CcSEcCtD
Mupirocin—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00269	0.00343	CcSEcCtD
Mupirocin—Erythema—Glyburide—type 2 diabetes mellitus	0.00269	0.00343	CcSEcCtD
Mupirocin—Rash—Linagliptin—type 2 diabetes mellitus	0.00268	0.00342	CcSEcCtD
Mupirocin—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00268	0.00341	CcSEcCtD
Mupirocin—Epistaxis—Valsartan—type 2 diabetes mellitus	0.00268	0.00341	CcSEcCtD
Mupirocin—Headache—Linagliptin—type 2 diabetes mellitus	0.00266	0.00339	CcSEcCtD
Mupirocin—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00266	0.00339	CcSEcCtD
Mupirocin—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00265	0.00338	CcSEcCtD
Mupirocin—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00265	0.00338	CcSEcCtD
Mupirocin—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00263	0.00335	CcSEcCtD
Mupirocin—Rash—Acarbose—type 2 diabetes mellitus	0.0026	0.00332	CcSEcCtD
Mupirocin—Dermatitis—Acarbose—type 2 diabetes mellitus	0.0026	0.00331	CcSEcCtD
Mupirocin—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00259	0.0033	CcSEcCtD
Mupirocin—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00257	0.00328	CcSEcCtD
Mupirocin—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.00256	0.00326	CcSEcCtD
Mupirocin—Rhinitis—Valsartan—type 2 diabetes mellitus	0.00255	0.00325	CcSEcCtD
Mupirocin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00255	0.00325	CcSEcCtD
Mupirocin—Nausea—Tolazamide—type 2 diabetes mellitus	0.00255	0.00325	CcSEcCtD
Mupirocin—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.00255	0.00325	CcSEcCtD
Mupirocin—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00254	0.00323	CcSEcCtD
Mupirocin—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.00253	0.00322	CcSEcCtD
Mupirocin—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.00253	0.00322	CcSEcCtD
Mupirocin—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.00252	0.00321	CcSEcCtD
Mupirocin—Rash—Nateglinide—type 2 diabetes mellitus	0.00251	0.0032	CcSEcCtD
Mupirocin—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00251	0.0032	CcSEcCtD
Mupirocin—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.0025	0.00318	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00249	0.00317	CcSEcCtD
Mupirocin—Angioedema—Glyburide—type 2 diabetes mellitus	0.00246	0.00313	CcSEcCtD
Mupirocin—Nausea—Acarbose—type 2 diabetes mellitus	0.00245	0.00312	CcSEcCtD
Mupirocin—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00245	0.00312	CcSEcCtD
Mupirocin—Pain—Glipizide—type 2 diabetes mellitus	0.00244	0.00311	CcSEcCtD
Mupirocin—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00244	0.00311	CcSEcCtD
Mupirocin—Erythema—Gliclazide—type 2 diabetes mellitus	0.00241	0.00308	CcSEcCtD
Mupirocin—Nausea—Nateglinide—type 2 diabetes mellitus	0.00236	0.00301	CcSEcCtD
Mupirocin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00236	0.003	CcSEcCtD
Mupirocin—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00233	0.00297	CcSEcCtD
Mupirocin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00233	0.00297	CcSEcCtD
Mupirocin—Rhinitis—Metformin—type 2 diabetes mellitus	0.00233	0.00296	CcSEcCtD
Mupirocin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.0023	0.00294	CcSEcCtD
Mupirocin—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.0023	0.00293	CcSEcCtD
Mupirocin—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.0023	0.00293	CcSEcCtD
Mupirocin—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.00227	0.0029	CcSEcCtD
Mupirocin—Pain—Sitagliptin—type 2 diabetes mellitus	0.00227	0.00289	CcSEcCtD
Mupirocin—Urticaria—Glipizide—type 2 diabetes mellitus	0.00226	0.00289	CcSEcCtD
Mupirocin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00225	0.00287	CcSEcCtD
Mupirocin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00223	0.00284	CcSEcCtD
Mupirocin—Angioedema—Gliclazide—type 2 diabetes mellitus	0.0022	0.00281	CcSEcCtD
Mupirocin—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.00219	0.0028	CcSEcCtD
Mupirocin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00217	0.00277	CcSEcCtD
Mupirocin—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.00217	0.00277	CcSEcCtD
Mupirocin—Rash—Repaglinide—type 2 diabetes mellitus	0.00217	0.00277	CcSEcCtD
Mupirocin—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.00217	0.00277	CcSEcCtD
Mupirocin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00217	0.00277	CcSEcCtD
Mupirocin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00217	0.00276	CcSEcCtD
Mupirocin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00217	0.00276	CcSEcCtD
Mupirocin—Epistaxis—Losartan—type 2 diabetes mellitus	0.00216	0.00276	CcSEcCtD
Mupirocin—Headache—Repaglinide—type 2 diabetes mellitus	0.00216	0.00275	CcSEcCtD
Mupirocin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00215	0.00274	CcSEcCtD
Mupirocin—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.00215	0.00273	CcSEcCtD
Mupirocin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00211	0.00269	CcSEcCtD
Mupirocin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00211	0.00268	CcSEcCtD
Mupirocin—Cough—Gliclazide—type 2 diabetes mellitus	0.00211	0.00268	CcSEcCtD
Mupirocin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.0021	0.00268	CcSEcCtD
Mupirocin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.0021	0.00268	CcSEcCtD
Mupirocin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.0021	0.00267	CcSEcCtD
Mupirocin—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00209	0.00267	CcSEcCtD
Mupirocin—Rhinitis—Losartan—type 2 diabetes mellitus	0.00206	0.00263	CcSEcCtD
Mupirocin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00205	0.00262	CcSEcCtD
Mupirocin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00205	0.00261	CcSEcCtD
Mupirocin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00205	0.00261	CcSEcCtD
Mupirocin—Pharyngitis—Losartan—type 2 diabetes mellitus	0.00204	0.00261	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00204	0.0026	CcSEcCtD
Mupirocin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00204	0.0026	CcSEcCtD
Mupirocin—Angioedema—Valsartan—type 2 diabetes mellitus	0.00203	0.00258	CcSEcCtD
Mupirocin—Erythema—Metformin—type 2 diabetes mellitus	0.00202	0.00257	CcSEcCtD
Mupirocin—Pruritus—Glipizide—type 2 diabetes mellitus	0.00202	0.00257	CcSEcCtD
Mupirocin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00201	0.00256	CcSEcCtD
Mupirocin—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00201	0.00256	CcSEcCtD
Mupirocin—Angioedema—Orlistat—type 2 diabetes mellitus	0.002	0.00255	CcSEcCtD
Mupirocin—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00198	0.00252	CcSEcCtD
Mupirocin—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00198	0.00252	CcSEcCtD
Mupirocin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00196	0.0025	CcSEcCtD
Mupirocin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00196	0.0025	CcSEcCtD
Mupirocin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00195	0.00249	CcSEcCtD
Mupirocin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00195	0.00249	CcSEcCtD
Mupirocin—Cough—Valsartan—type 2 diabetes mellitus	0.00193	0.00247	CcSEcCtD
Mupirocin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00193	0.00246	CcSEcCtD
Mupirocin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00191	0.00244	CcSEcCtD
Mupirocin—Cough—Orlistat—type 2 diabetes mellitus	0.00191	0.00244	CcSEcCtD
Mupirocin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00191	0.00243	CcSEcCtD
Mupirocin—Erythema—Irbesartan—type 2 diabetes mellitus	0.00191	0.00243	CcSEcCtD
Mupirocin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.0019	0.00242	CcSEcCtD
Mupirocin—Dizziness—Glipizide—type 2 diabetes mellitus	0.00188	0.0024	CcSEcCtD
Mupirocin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00188	0.0024	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00187	0.00239	CcSEcCtD
Mupirocin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00187	0.00238	CcSEcCtD
Mupirocin—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00187	0.00238	CcSEcCtD
Mupirocin—Epistaxis—Ramipril—type 2 diabetes mellitus	0.00186	0.00237	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00185	0.00236	CcSEcCtD
Mupirocin—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00185	0.00235	CcSEcCtD
Mupirocin—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00182	0.00232	CcSEcCtD
Mupirocin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00182	0.00232	CcSEcCtD
Mupirocin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00181	0.00231	CcSEcCtD
Mupirocin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00181	0.00231	CcSEcCtD
Mupirocin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00181	0.0023	CcSEcCtD
Mupirocin—Rash—Glipizide—type 2 diabetes mellitus	0.0018	0.00229	CcSEcCtD
Mupirocin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.0018	0.00229	CcSEcCtD
Mupirocin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00179	0.00229	CcSEcCtD
Mupirocin—Erythema—Losartan—type 2 diabetes mellitus	0.00179	0.00229	CcSEcCtD
Mupirocin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00179	0.00228	CcSEcCtD
Mupirocin—Headache—Glipizide—type 2 diabetes mellitus	0.00179	0.00228	CcSEcCtD
Mupirocin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00176	0.00224	CcSEcCtD
Mupirocin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00176	0.00224	CcSEcCtD
Mupirocin—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00176	0.00224	CcSEcCtD
Mupirocin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00175	0.00223	CcSEcCtD
Mupirocin—Urticaria—Glyburide—type 2 diabetes mellitus	0.00174	0.00222	CcSEcCtD
Mupirocin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00174	0.00222	CcSEcCtD
Mupirocin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00174	0.00221	CcSEcCtD
Mupirocin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00173	0.00221	CcSEcCtD
Mupirocin—Headache—Pioglitazone—type 2 diabetes mellitus	0.00171	0.00218	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00171	0.00218	CcSEcCtD
Mupirocin—Nausea—Glipizide—type 2 diabetes mellitus	0.00169	0.00216	CcSEcCtD
Mupirocin—Pain—Gliclazide—type 2 diabetes mellitus	0.00168	0.00215	CcSEcCtD
Mupirocin—Rash—Glimepiride—type 2 diabetes mellitus	0.00168	0.00214	CcSEcCtD
Mupirocin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00168	0.00214	CcSEcCtD
Mupirocin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00167	0.00213	CcSEcCtD
Mupirocin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00167	0.00213	CcSEcCtD
Mupirocin—Headache—Glimepiride—type 2 diabetes mellitus	0.00167	0.00212	CcSEcCtD
Mupirocin—Cough—Irbesartan—type 2 diabetes mellitus	0.00166	0.00212	CcSEcCtD
Mupirocin—Headache—Sitagliptin—type 2 diabetes mellitus	0.00166	0.00212	CcSEcCtD
Mupirocin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00164	0.00209	CcSEcCtD
Mupirocin—Angioedema—Losartan—type 2 diabetes mellitus	0.00164	0.00209	CcSEcCtD
Mupirocin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00162	0.00206	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00161	0.00205	CcSEcCtD
Mupirocin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00161	0.00205	CcSEcCtD
Mupirocin—Skin disorder—Metformin—type 2 diabetes mellitus	0.0016	0.00204	CcSEcCtD
Mupirocin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.0016	0.00203	CcSEcCtD
Mupirocin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00159	0.00202	CcSEcCtD
Mupirocin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00159	0.00202	CcSEcCtD
Mupirocin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00158	0.00201	CcSEcCtD
Mupirocin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00157	0.00201	CcSEcCtD
Mupirocin—Cough—Losartan—type 2 diabetes mellitus	0.00156	0.00199	CcSEcCtD
Mupirocin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00156	0.00199	CcSEcCtD
Mupirocin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00156	0.00198	CcSEcCtD
Mupirocin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00155	0.00198	CcSEcCtD
Mupirocin—Pruritus—Glyburide—type 2 diabetes mellitus	0.00155	0.00198	CcSEcCtD
Mupirocin—Erythema—Ramipril—type 2 diabetes mellitus	0.00154	0.00196	CcSEcCtD
Mupirocin—Pain—Orlistat—type 2 diabetes mellitus	0.00153	0.00195	CcSEcCtD
Mupirocin—Rash—Bromocriptine—type 2 diabetes mellitus	0.00151	0.00193	CcSEcCtD
Mupirocin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00151	0.00193	CcSEcCtD
Mupirocin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00151	0.00193	CcSEcCtD
Mupirocin—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00151	0.00192	CcSEcCtD
Mupirocin—Headache—Bromocriptine—type 2 diabetes mellitus	0.0015	0.00192	CcSEcCtD
Mupirocin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.0015	0.00191	CcSEcCtD
Mupirocin—Dry mouth—Losartan—type 2 diabetes mellitus	0.00149	0.0019	CcSEcCtD
Mupirocin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00148	0.00189	CcSEcCtD
Mupirocin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00146	0.00187	CcSEcCtD
Mupirocin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00146	0.00186	CcSEcCtD
Mupirocin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00145	0.00185	CcSEcCtD
Mupirocin—Urticaria—Valsartan—type 2 diabetes mellitus	0.00144	0.00183	CcSEcCtD
Mupirocin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00143	0.00182	CcSEcCtD
Mupirocin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00143	0.00182	CcSEcCtD
Mupirocin—Urticaria—Orlistat—type 2 diabetes mellitus	0.00142	0.00181	CcSEcCtD
Mupirocin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00141	0.0018	CcSEcCtD
Mupirocin—Angioedema—Ramipril—type 2 diabetes mellitus	0.0014	0.00179	CcSEcCtD
Mupirocin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00139	0.00178	CcSEcCtD
Mupirocin—Rash—Glyburide—type 2 diabetes mellitus	0.00138	0.00176	CcSEcCtD
Mupirocin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00138	0.00176	CcSEcCtD
Mupirocin—Headache—Glyburide—type 2 diabetes mellitus	0.00137	0.00175	CcSEcCtD
Mupirocin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00135	0.00172	CcSEcCtD
Mupirocin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00135	0.00172	CcSEcCtD
Mupirocin—Cough—Ramipril—type 2 diabetes mellitus	0.00134	0.00171	CcSEcCtD
Mupirocin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00133	0.0017	CcSEcCtD
Mupirocin—Pain—Irbesartan—type 2 diabetes mellitus	0.00133	0.00169	CcSEcCtD
Mupirocin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00132	0.00168	CcSEcCtD
Mupirocin—Urticaria—Metformin—type 2 diabetes mellitus	0.00131	0.00167	CcSEcCtD
Mupirocin—Nausea—Glyburide—type 2 diabetes mellitus	0.0013	0.00166	CcSEcCtD
Mupirocin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.0013	0.00166	CcSEcCtD
Mupirocin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.0013	0.00166	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.0013	0.00166	CcSEcCtD
Mupirocin—Pruritus—Valsartan—type 2 diabetes mellitus	0.00128	0.00163	CcSEcCtD
Mupirocin—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00128	0.00163	CcSEcCtD
Mupirocin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00127	0.00162	CcSEcCtD
Mupirocin—Pruritus—Orlistat—type 2 diabetes mellitus	0.00126	0.00161	CcSEcCtD
Mupirocin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00125	0.0016	CcSEcCtD
Mupirocin—Pain—Losartan—type 2 diabetes mellitus	0.00125	0.0016	CcSEcCtD
Mupirocin—Rash—Gliclazide—type 2 diabetes mellitus	0.00124	0.00158	CcSEcCtD
Mupirocin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00124	0.00158	CcSEcCtD
Mupirocin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00124	0.00158	CcSEcCtD
Mupirocin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00124	0.00157	CcSEcCtD
Mupirocin—Headache—Gliclazide—type 2 diabetes mellitus	0.00123	0.00157	CcSEcCtD
Mupirocin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00123	0.00157	CcSEcCtD
Mupirocin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00122	0.00156	CcSEcCtD
Mupirocin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00122	0.00155	CcSEcCtD
Mupirocin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.0012	0.00153	CcSEcCtD
Mupirocin—Dizziness—Valsartan—type 2 diabetes mellitus	0.0012	0.00153	CcSEcCtD
Mupirocin—Dizziness—Orlistat—type 2 diabetes mellitus	0.00118	0.00151	CcSEcCtD
Mupirocin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00117	0.00149	CcSEcCtD
Mupirocin—Pruritus—Metformin—type 2 diabetes mellitus	0.00117	0.00149	CcSEcCtD
Mupirocin—Urticaria—Losartan—type 2 diabetes mellitus	0.00116	0.00148	CcSEcCtD
Mupirocin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00116	0.00147	CcSEcCtD
Mupirocin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00115	0.00146	CcSEcCtD
Mupirocin—Rash—Valsartan—type 2 diabetes mellitus	0.00114	0.00145	CcSEcCtD
Mupirocin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00114	0.00145	CcSEcCtD
Mupirocin—Headache—Valsartan—type 2 diabetes mellitus	0.00113	0.00144	CcSEcCtD
Mupirocin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00113	0.00144	CcSEcCtD
Mupirocin—Rash—Orlistat—type 2 diabetes mellitus	0.00113	0.00144	CcSEcCtD
Mupirocin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00113	0.00144	CcSEcCtD
Mupirocin—Headache—Orlistat—type 2 diabetes mellitus	0.00112	0.00143	CcSEcCtD
Mupirocin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.0011	0.0014	CcSEcCtD
Mupirocin—Dizziness—Metformin—type 2 diabetes mellitus	0.00109	0.00139	CcSEcCtD
Mupirocin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00108	0.00137	CcSEcCtD
Mupirocin—Nausea—Valsartan—type 2 diabetes mellitus	0.00107	0.00137	CcSEcCtD
Mupirocin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00106	0.00136	CcSEcCtD
Mupirocin—Nausea—Orlistat—type 2 diabetes mellitus	0.00106	0.00135	CcSEcCtD
Mupirocin—Rash—Metformin—type 2 diabetes mellitus	0.00104	0.00132	CcSEcCtD
Mupirocin—Dermatitis—Metformin—type 2 diabetes mellitus	0.00104	0.00132	CcSEcCtD
Mupirocin—Pruritus—Losartan—type 2 diabetes mellitus	0.00104	0.00132	CcSEcCtD
Mupirocin—Headache—Metformin—type 2 diabetes mellitus	0.00103	0.00132	CcSEcCtD
Mupirocin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00103	0.00131	CcSEcCtD
Mupirocin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00103	0.00131	CcSEcCtD
Mupirocin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.001	0.00128	CcSEcCtD
Mupirocin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000997	0.00127	CcSEcCtD
Mupirocin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000992	0.00126	CcSEcCtD
Mupirocin—Rash—Irbesartan—type 2 diabetes mellitus	0.00098	0.00125	CcSEcCtD
Mupirocin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000979	0.00125	CcSEcCtD
Mupirocin—Nausea—Metformin—type 2 diabetes mellitus	0.000979	0.00125	CcSEcCtD
Mupirocin—Headache—Irbesartan—type 2 diabetes mellitus	0.000974	0.00124	CcSEcCtD
Mupirocin—Dizziness—Losartan—type 2 diabetes mellitus	0.000968	0.00123	CcSEcCtD
Mupirocin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000924	0.00118	CcSEcCtD
Mupirocin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000924	0.00118	CcSEcCtD
Mupirocin—Rash—Losartan—type 2 diabetes mellitus	0.000923	0.00118	CcSEcCtD
Mupirocin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000922	0.00117	CcSEcCtD
Mupirocin—Headache—Losartan—type 2 diabetes mellitus	0.000917	0.00117	CcSEcCtD
Mupirocin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000888	0.00113	CcSEcCtD
Mupirocin—Nausea—Losartan—type 2 diabetes mellitus	0.000869	0.00111	CcSEcCtD
Mupirocin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000859	0.00109	CcSEcCtD
Mupirocin—Dizziness—Ramipril—type 2 diabetes mellitus	0.00083	0.00106	CcSEcCtD
Mupirocin—Rash—Ramipril—type 2 diabetes mellitus	0.000791	0.00101	CcSEcCtD
Mupirocin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00079	0.00101	CcSEcCtD
Mupirocin—Headache—Ramipril—type 2 diabetes mellitus	0.000786	0.001	CcSEcCtD
Mupirocin—Nausea—Ramipril—type 2 diabetes mellitus	0.000745	0.00095	CcSEcCtD
